Price T Rowe Associates Inc Pds Biotechnology Corp Transaction History
Price T Rowe Associates Inc
- $869 Billion
- Q3 2024
A detailed history of Price T Rowe Associates Inc transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 24,900 shares of PDSB stock, worth $53,535. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,900
Previous 24,900
-0.0%
Holding current value
$53,535
Previous $73,000
31.51%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PDSB
# of Institutions
64Shares Held
4.32MCall Options Held
253KPut Options Held
70.4K-
Vanguard Group Inc Valley Forge, PA1.52MShares$3.27 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$1.05 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA415KShares$892,4920.0% of portfolio
-
Inspirion Wealth Advisors, LLC344KShares$740,4470.18% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny234KShares$503,5490.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $61.2M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...